Hepatobiliary Cancers

被引：386

作者：

Benson, Al B., III ^{[1
]}

Abrams, Thomas A. ^{[2
]}

Ben-Josef, Edgar ^{[3
]}

Bloomston, P. Mark ^{[4
]}

Botha, Jean F. ^{[5
]}

Clary, Bryan M.

Covey, Anne

Curley, Steven A. ^{[6
]}

D'Angelica, Michael I.

Davila, Rene ^{[7
]}

Ensminger, William D. ^{[3
]}

Gibbs, John F.

Laheru, Daniel ^{[8
]}

Malafa, Mokenge P.

Marrero, Jorge ^{[3
]}

Meranze, Steven G.

Mulvihill, Sean J. ^{[9
]}

Park, James O. ^{[10
]}

Posey, James A. ^{[11
]}

Sachdev, Jasgit ^{[7
]}

Salem, Riad ^{[1
]}

Sigurdson, Elin R.

Sofocleous, Constantinos

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[3] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[4] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA

[5] Nebraska Med Ctr, UNMC Eppley Canc Ctr, Lincoln, NE USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[7] Univ Tennessee, St Jude Childrens Res Hosp, Inst Canc, Knoxville, TN 37996 USA

[8] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[9] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[10] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[11] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 04期

关键词：

NCCN Clinical Practice Guidelines; hepatocellular carcinoma; hepatitis; cirrhosis; surgical resection; gallbladder cancer; cholangiocarcinomas; transplantation; tumor ablation; chemoembolization; chemotherapy; biologic therapy; EARLY HEPATOCELLULAR-CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; ADVANCED BILIARY-TRACT; NONALCOHOLIC FATTY LIVER; POSITRON-EMISSION-TOMOGRAPHY; 7 STAGING SYSTEMS; PERCUTANEOUS RADIOFREQUENCY ABLATION; PORTAL-VEIN EMBOLIZATION; LONG-TERM SURVIVAL; PHASE-II;

D O I：

10.6004/jnccn.2009.0027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although many patients with hepatobiliary cancers are diagnosed at an advanced stage, all patients should be evaluated for treatment. Nevertheless, careful patient selection for treatment and active multidisciplinary cooperation are essential. Very few high-quality randomized clinical trials of patients with hepatobiliary cancers exist, and patient participation in prospective clinical trials is the preferred option for treatment of patients with all stages of disease. © Journal of the National Comprehensive Cancer Network.

引用

页码：350 / 391

页数：42

共 225 条

[1] Treatment of large and advanced hepatocellular carcinoma [J].

Abdalla, Eddie K. ;

Denys, Alban ;

Hasegawa, Kiyoshi ;

Leung, Thomas W. T. ;

Makuuchi, Masatoshi ;

Murthy, Ravi ;

Ribero, Dario ;

Zorzi, Daria ;

Vauthey, Jean-Nicolas ;

Torzilli, Guido .

ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (04) :979-985

[2] Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? [J].

Abou-Alfa, G. K. ;

Amadori, D. ;

Santoro, A. ;

Figer, A. ;

De Greve, J. ;

Lathia, C. ;

Voliotis, D. ;

Anderson, S. ;

Moscovici, M. ;

Ricci, S. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[3] Phase II study of sorafenib in patients with advanced hepatocellular carcinoma [J].

Abou-Alfa, Ghassan K. ;

Schwartz, Lawrence ;

Ricci, Sergio ;

Amadori, Dino ;

Santoro, Armando ;

Figer, Arie ;

De Greve, Jacques ;

Douillard, Jean-Yves ;

Lathia, Chetan ;

Schwartz, Brian ;

Taylor, Ian ;

Moscovici, Marius ;

Saltz, Leonard B. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4293-4300

[4] Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life [J].

Abraham, NS ;

Barkun, JS ;

Barkun, AN .

GASTROINTESTINAL ENDOSCOPY, 2002, 56 (06) :835-841

[5] Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma - A north central cancer treatment group phase II trial [J].

Alberts, SR ;

Al-Khatib, H ;

Mahoney, MR ;

Burgart, L ;

Cera, PJ ;

Flynn, PJ ;

Finch, TR ;

Levitt, R ;

Windschitl, HE ;

Knost, JA ;

Tschetter, LK .

CANCER, 2005, 103 (01) :111-118

[6]

Alter M J, 1997, Clin Liver Dis, V1, P559, DOI 10.1016/S1089-3261(05)70321-4

[7] Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma:: a GERCOR study [J].

André, T ;

Tournigand, C ;

Rosmorduc, O ;

Provent, S ;

Maindrault-Goebel, F ;

Avenin, D ;

Selle, F ;

Paye, F ;

Hannoun, L ;

Houry, S ;

Gayet, B ;

Lotz, JP ;

de Gramont, A ;

Louvet, C .

ANNALS OF ONCOLOGY, 2004, 15 (09) :1339-1343

[8]

[Anonymous], J CLIN ONCOL S1

[9] Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis [J].

Asare, George A. ;

Bronz, Michelle ;

Naidoo, Vivash ;

Kew, Michael C. .

TOXICOLOGY, 2008, 254 (1-2) :11-18

[10] Multimodality imaging following 90Y radioembolization:: A comprehensive review and pictorial essay [J].

Atassi, Bassel ;

Bangash, Affaan K. ;

Bahram, Ammar ;

Pizzi, Giuseppi ;

Lewandowski, Robert J. ;

Ryu, Robert K. ;

Sato, Kent T. ;

Gates, Vanessa L. ;

Mulcahy, Mary F. ;

Kulik, Laura ;

Miller, Frank ;

Yaghmai, Vahid ;

Murth, Ravi ;

Larson, Andrew ;

Omary, Reed A. ;

Salem, Riad .

RADIOGRAPHICS, 2008, 28 (01) :81-99

← 1 2 3 4 5 6 7 8 9 10 →